At Infinity Med Spa, the most useful opening question is not simply whether it offers GLP-1 treatment. Its public documentation says it does. The harder question is which version of its program you would actually be buying. Across its general weight-loss page, medication pages and membership information, the practice publishes different starting monthly prices—and, for Ozempic, different numbers of check-in appointments. Those differences affect how a prospective patient should prepare for the first conversation.
Infinity describes a locally based medical weight-management service serving Valencia and Santa Clarita, California, within a broader aesthetic practice. Its pages discuss medical evaluation, possible laboratory testing, home injections, nutritional support and recurring monitoring. This documentary review examines those offerings through practical patient questions, using public pages consulted October 19, 2026. It does not verify staff licenses, establish individual eligibility or resolve the provider’s inconsistent terms. The aim is to identify what is documented and what still needs a clear answer before enrollment.
At a glance
- Location
- Infinity publishes one address: 25425 Orchard Village Road, Suite 180, Valencia, CA 91355.Sources: [7]
- Medication options
- The practice says it may prescribe semaglutide, Ozempic or tirzepatide after reviewing medical history and goals.Sources: [5]
- Conflicting monthly prices
- General-page starting prices are $195 for semaglutide and $295 for tirzepatide; their dedicated pages list starting prices of $395 and $595 per month, respectively.
- Separate entry charges
- Dedicated semaglutide and tirzepatide pages advertise a complimentary initial consultation but also list $200 laboratory charges and a $400 NP/PA consultation.
Start by asking which published offer applies
Infinity’s price differences are material enough that choosing the lowest advertised figure would not produce a dependable budget. The general page lists semaglutide “as low as” $195 per month, while the dedicated medication page says “starting at” $395. Tirzepatide moves from “as low as” $295 on the general page to $595 on its dedicated page. Both are starting figures rather than a documented universal charge. The consulted pages do not reconcile whether these reflect different packages, eligibility conditions or outdated offers.
Ozempic presents a similar problem: the general page advertises a program from $195 monthly, while the membership page advertises it from $395. Both separately identify a $1,300 pen. Ask the office to name the applicable program, provide its current written price and explain which public description it replaces. Our guide to price questions beyond the monthly headline can help organize that conversation without treating an advertised minimum as the total.
The table captures the differences worth bringing to the consultation. It is not a menu of interchangeable offers or a calculation of treatment costs. In particular, the semaglutide and tirzepatide descriptions do not consistently establish whether the monthly amount includes the entire medication cost. Ask for an itemized quote that distinguishes membership services, medication, testing and clinical review, and that states whether your own price could change.
| Program | General weight-loss page | Other program documentation |
|---|---|---|
| Semaglutide | From $195/month | Dedicated page: from $395/month; $200 labs and $400 NP/PA consultation listed |
| Tirzepatide | From $295/month | Dedicated page: from $595/month; $200 bloodwork and $400 NP/PA consultation listed |
| Ozempic | From $195/month; $1,300 pen separately | Membership page: from $395/month; $200 bloodwork, $400 NP/PA consultation and $1,300 pen listed |
| Tirzepatide micro-dose membership | From $395/month | Dedicated page: from $295/month; described as maintenance after initial weight loss |
| Semaglutide micro-dose membership | From $195/month | Confirm applicable package and medication inclusion |
Separate the free introduction from paid clinical work
A complimentary initial consultation is repeatedly advertised, including free weight-loss consultations Monday through Saturday. However, the dedicated semaglutide page also lists a $200 laboratory testing fee and a $400 consultation with a nurse practitioner or physician assistant to review results and the treatment plan. Tirzepatide lists the same amounts for bloodwork and an NP/PA review of laboratory results and medical history. The Ozempic membership page also lists those charges. Free introductory access therefore does not mean cost-free enrollment.
The program begins, according to Infinity, with evaluation of medical history, lifestyle habits and nutritional status. It says laboratory work may investigate hormonal imbalances, nutrient deficiencies or food sensitivities. Separately, the general page’s Ozempic information asks patients to supply bloodwork from within the previous 12 months. Ask whether existing results can satisfy the current program’s requirements, what testing is actually being ordered and whether the published testing fee remains applicable when outside results are accepted.
The consultation is also described as a decision point, not a guaranteed prescription. Infinity says its medical providers review goals and history before determining whether someone is a candidate for medication. Its website terms restrict site use to adults 18 or older, but that is not a complete treatment eligibility policy. Before paying for clinical work, ask what happens financially if the evaluation does not lead to a prescription and which services, if any, remain available.
Identify the exact medicine and its dispensing route
Infinity says it may prescribe semaglutide, Ozempic or tirzepatide according to medical history and goals. Its dedicated semaglutide and tirzepatide pages describe instruction for once-weekly injections administered at home. That establishes an advertised route and a training component, not the exact product a particular patient receives. The consulted documentation does not identify a dispensing pharmacy or resolve whether unbranded semaglutide and tirzepatide are commercial products or compounded preparations. Neither possibility should be assumed from the ingredient name alone.
Ask for the medication’s full name, formulation, presentation, manufacturer or compounding pharmacy, and the party responsible for dispensing it. Also ask whether the medicine is collected at the office, obtained from a pharmacy or delivered. Our guide to identifying the medicine before comparing offers provides a practical framework. Infinity’s published estimate that an Ozempic pen lasts approximately 12 weeks should not be treated as a promise about your prescription, quantity, regimen or minimum membership duration.
If compounding is proposed, FDA says compounded preparations are not FDA approved and recommends them when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence. This is general regulatory context, not a finding about Infinity’s products. Because the documentation leaves product identity unresolved, the provider should explain the actual preparation rather than relying on broad statements about an ingredient or medication class.
Find out who owns each part of your care
Infinity is a med spa offering noninvasive cosmetic services as well as medical weight management. It identifies Dr. Van J. Veloso as medical director and practice owner. Its team page presents Nicole Phillips as FNP-BC, with a focus including aesthetics, hormone optimization and weight management, and Kelly McCurdy as PA-C, with experience including family medicine, medical weight loss and aesthetic medicine. These are provider-published biographies, not independently verified credentials or a guarantee that a named professional will handle your appointments.
The practice states that medical treatments are performed only by a licensed doctor, nurse practitioner, physician assistant or registered nurse. That statement does not specify which professional conducts initial assessment, prescribes medication, teaches injections or answers later clinical questions. Ask who your prescribing clinician would be, whether follow-up is with that same person and how concerns move between staff members. A registered nurse’s involvement in treatment should not be confused with identification of the clinician responsible for prescribing.
The documented physical location is 25425 Orchard Village Road, Suite 180, Valencia, California 91355. Infinity markets weight-loss services to Valencia and Santa Clarita, but the consulted pages do not establish multistate coverage or a telemedicine pathway. General business hours are Monday through Friday, 9 a.m.–6 p.m., and Saturday and Sunday, 10 a.m.–5 p.m. Those hours are not necessarily weight-management appointment availability; the separate free-consultation statement specifies Monday through Saturday.
Make monthly follow-up concrete
The dedicated semaglutide page says its $395 monthly program includes one follow-up visit, weight and body-composition analysis, ongoing dosage management as needed, and complimentary nutrition guidance with a diet plan. Tirzepatide’s $595 monthly description similarly includes one follow-up, body-composition analysis, personalized treatment adjustments and a diet plan. These are meaningful documented service components. Still, ask how long appointments last, who conducts them and whether medication-related questions between visits are included or billed separately.
Ozempic’s follow-up schedule is less consistent. The general page’s $195 monthly charge covers one check-in, a multistep weight and body-mass assessment, and a diet plan. The membership page lists two monthly check-ins alongside its higher starting program price. Ask whether this represents a different service tier or an unreconciled description. A written appointment schedule is more useful than assuming the page with more visits controls, particularly if regular in-person attendance affects your work or travel arrangements.
Infinity also says it uses body-composition analysis and metabolic testing to monitor progress and adjust treatment plans. Its broader plan may include dietary changes, exercise recommendations, behavioral therapy and procedures. The word “may” matters: it does not establish that every component is included in every membership. Ask which assessments occur routinely, which are optional, whether behavioral support is actually delivered within your package and whether any additional procedure requires separate consent and payment.
Ask what happens between appointments
Infinity publishes a telephone number, 661-220-5102, a text number, 661-259-8100, and an online consultation request. Those are useful access paths, but they do not establish clinical response times, urgent coverage or direct access to the prescriber. Before starting, ask which channel is appropriate for medication questions, what happens outside office hours and who handles a problem when your usual clinician is unavailable. Administrative texting should not be assumed to provide continuous clinical monitoring.
Home injection instruction is explicitly described, but the public documentation does not explain pharmacy coordination, shipping, refrigeration arrangements or delivery troubleshooting. These omissions matter if your proposed arrangement involves shipped medication rather than local collection. Ask which organization handles a missing package, replacement requests and storage concerns. As general FDA guidance, an injectable GLP-1 product that arrives warm or inadequately refrigerated should not be used; contact the provider or dispensing pharmacy to resolve the concern.
Ask to receive clear written administration instructions from the treating team and a contact for clarification, rather than relying on a review to interpret quantities or measurements. FDA reports include errors in measuring or administering compounded medication, sometimes associated with hospitalization; those reports are not an Infinity-specific event rate. Infinity’s promise of instruction is helpful documentation, but the practical question is how patients obtain additional teaching when the first explanation or the dispensed presentation leaves something unclear.
Distinguish micro-dose marketing from established terms
Infinity advertises a semaglutide micro-dose membership starting at $195 monthly. For tirzepatide micro-dose membership, the general page starts at $395, while the dedicated tirzepatide page starts at $295. The dedicated tirzepatide page describes this membership as maintenance for patients who have already achieved initial weight loss. Confirm whether that description applies to the package offered to you. These figures should not be substituted for the standard program prices or treated as evidence that a lower-priced package is appropriate for a new patient. Ask what the membership name means operationally, whom the clinic offers it to and which medication and services the quoted price actually covers.
The presence of a micro-dose offer is not evidence of its clinical effectiveness, nor do studies of particular semaglutide or tirzepatide regimens establish results for a clinic’s differently described program. The original STEP 1 and SURMOUNT-1 trials were not trials of Infinity or its micro-dose memberships. Rather than borrowing headline trial percentages, ask what evidence supports the exact proposed approach and how the clinician will evaluate response and tolerability. Public marketing language cannot answer those individualized questions.
Infinity also advertises ancillary discounts for Ozempic and semaglutide members: 20% off spa and laser services, 10% off injectables, 10% off skin-care products, and 20% off weight-loss or health supplements. These are commercial benefits, not additional evidence about medication outcomes. Keep them separate from your assessment of clinical follow-up and total treatment costs. They also should not be assumed to extend to tirzepatide members, since the cited membership description specifically names Ozempic and semaglutide.
Get the exit and payment rules before enrolling
The consulted documentation does not settle minimum commitments, automatic renewals, prepayment requirements, membership cancellation, refunds or missed-appointment charges. It also does not provide a clear insurance-billing policy. Ask when the first charge occurs, what authorizes later charges, what notice is required to stop them and whether any payments are refundable. Our checklist of questions before the next charge is useful here because a monthly advertised price alone does not explain the ongoing commitment.
Infinity advertises 0% financing options, but the consulted text does not supply detailed financial terms. Ask which charges can be financed and request the actual payment agreement rather than assuming every patient or service qualifies. Separately, determine whether the office bills insurance and whether your plan covers the prescribed medicine; those are different questions. NIDDK notes that coverage for weight-management medicines varies by plan, so neither a membership quote nor a clinic visit establishes medication reimbursement.
The website terms allow users to stop transactional SMS messages by replying STOP, with HELP or contactus@infinitymedspa.com available for assistance. That stops a messaging service; it is not a documented treatment-cancellation procedure. The website terms also select New York law and courts despite the published California practice address. Without drawing legal conclusions, ask for the actual patient and membership agreements. Our provider-fit questions can help separate website boilerplate from the commitments governing care.
Questions & answers
Is Infinity Med Spa a nationwide online GLP-1 service?
The documented model is a Valencia-based practice advertising medical weight management to Valencia and Santa Clarita. Its pages describe home injections, but that does not establish remote prescribing, nationwide availability or shipping. If you live outside the area, confirm the location and attendance requirements before scheduling or paying.
Does the free consultation include the laboratory review?
Do not assume so. The dedicated semaglutide and tirzepatide pages distinguish a complimentary initial consultation from $200 testing and a $400 NP/PA consultation. Ask what the free meeting covers, when paid clinical work begins and whether existing bloodwork changes the testing requirements or charges.
Is Ozempic included in the advertised monthly fee?
Infinity separately lists a $1,300 Ozempic pen, alongside a program advertised from $195 monthly on the general page or $395 on the membership page. The practice estimates approximately 12 weeks per pen. Ask for the applicable service fee and the medication charge separately; the estimate is not individualized supply guidance.
Can I tell whether the unbranded medications are compounded?
Not from the consulted documentation. Infinity names semaglutide and tirzepatide and describes home injection instruction, but the pages do not identify the dispensing pharmacy or conclusively identify those preparations. Request the exact product and dispensing details before comparing its offer with a branded prescription or another provider’s package.
How many Ozempic check-ins are included each month?
The general page lists one monthly check-in, while the membership page lists two. Neither description should automatically override the other. Ask the office to identify your package in writing, including the number of visits, who conducts them and whether additional appointments or between-visit clinical assistance carry separate fees.
Does texting STOP cancel an Infinity membership?
The website terms describe STOP as cancellation of the SMS service only. They do not establish a membership or treatment cancellation process. Obtain that process separately, including any notice deadline, future billing cutoff and refund rules. Keep confirmation of a cancellation request rather than relying on the absence of further text messages.
Our assessment
Infinity documents more than a medication advertisement: it describes clinical assessment, home-injection instruction, monthly monitoring, body-composition checks and nutritional support at a local practice. Those features give prospective patients concrete topics to discuss. The principal weakness is that its public offer is not consistently defined. Conflicting starting prices, different Ozempic visit counts, separate entry charges and unresolved medication sourcing prevent a reliable total-cost or service comparison. A useful next step is a written proposal naming the exact medicine, responsible clinician, dispensing arrangement, included appointments, initial charges and cancellation rules. If Infinity can reconcile those points clearly, the consultation can become a meaningful fit assessment; the public pages alone do not finish that work.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Infinity Med Spa / Infinity MedSpa — services/body/medical weight loss ↗
- Infinity Med Spa / Infinity MedSpa — about/financing ↗
- Infinity Med Spa / Infinity MedSpa — about ↗
- Infinity Med Spa / Infinity MedSpa — services/body/medical weight loss/semaglutide ↗
- Infinity Med Spa / Infinity MedSpa — about/memberships ↗
- Infinity Med Spa / Infinity MedSpa — about/meet our team ↗
- Infinity Med Spa / Infinity MedSpa — official website ↗
- Infinity Med Spa / Infinity MedSpa — services/body/medical weight loss/tirzepatide ↗
- Infinity Med Spa / Infinity MedSpa — terms of service ↗